PRESS RELEASE published on 01/19/2024 at 23:05, 2 years 9 months ago ROSEN, A LEADING NATIONAL FIRM, Encourages British American Tobacco p.l.c. Investors to Inquire About Securities Class Action Investigation - BTI The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of British American Tobacco p.l.c. (NYSE: BTI) shareholders for possible misleading business information. Shareholders who have purchased British American Tobacco securities may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the prospective class action seeking recovery of investor losses, individuals can visit their website or contact their toll-free number or email for more information. The Rosen Law Firm has a successful track record in securities class actions and shareholder derivative litigation, including achieving the largest ever securities class action settlement against a Chinese Company and recovering hundreds of millions of dollars for investors. Rosen Law Firm Securities Class Action Investor Rights British American Tobacco Shareholder Compensation
PRESS RELEASE published on 01/19/2024 at 23:04, 2 years 9 months ago ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ON Semiconductor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ON The Rosen Law Firm, a leading global investor rights law firm, encourages ON Semiconductor Corporation investors to secure counsel before the important deadline in the securities class action. If you purchased onsemi common stock during the Class Period, you may be entitled to compensation. The Rosen Law Firm has a track record of success in leadership roles and represents investors worldwide. Act now to protect your rights and seek qualified counsel. Rosen Law Firm Securities Class Action Investor Rights ON Semiconductor Corporation Compensation
PRESS RELEASE published on 01/19/2024 at 22:02, 2 years 9 months ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brooge Energy Limited Investors to Inquire About Securities Class Action Investigation - BROG The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of shareholders of Brooge Energy Limited. The firm believes that Brooge may have issued misleading business information to the investing public, resulting in potential financial losses for investors. Interested investors are encouraged to contact the firm to inquire about joining the prospective class action and seeking recovery of investor losses without payment of any out-of-pocket fees or costs. Through its extensive experience and successful track record, The Rosen Law Firm has recovered substantial amounts for investors in securities class actions and shareholder derivative litigation, making them a reliable choice for investors seeking legal representation in such matters. Rosen Law Firm Investor Rights Securities Claims Brooge Energy Limited Class Action Investigation
PRESS RELEASE published on 01/19/2024 at 22:02, 2 years 9 months ago ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important January 30 Deadline in Securities Class Action - LPSN Rosen Law Firm, a global investor rights law firm, encourages LivePerson, Inc. investors to secure counsel before the important January 30 deadline in the securities class action. The lawsuit alleges misleading statements and withholding of material information by LivePerson, leading to financial damages for investors. Investors may be entitled to compensation and are urged to seek qualified counsel to protect their rights. Rosen Law Firm Securities Class Action Investor Rights LivePerson Inc. Financial Damages
PRESS RELEASE published on 01/19/2024 at 21:04, 2 years 9 months ago ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX The Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of BioNTech SE investors. The lawsuit alleges that BioNTech made materially false and misleading statements regarding its business and operations, overstating demand for its COVID-19 vaccine and accumulating excess inventory. Investors who purchased BioNTech securities during the specified period may be entitled to compensation and are encouraged to seek qualified counsel before the March 12, 2024 deadline. Rosen Law Firm BioNTech SE Securities Class Action Investor Rights COVID-19 Vaccine
Published on 10/23/2026 at 02:20, 3 hours 56 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 6 hours 46 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 7 hours 46 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 14 hours 16 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 15 hours 46 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 06:05, 11 minutes ago Baccarat Hotel & Residences Maldives Unveils New Campaign featuring Adriana Lima
Published on 10/23/2026 at 01:55, 4 hours 21 minutes ago Guardian. For Family|TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 8 hours 6 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 10 hours 16 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 10 hours 31 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:00, 12 hours 16 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 12 hours 16 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 12 hours 16 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 12 hours 16 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 12 hours 16 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration